0004BIOT
0004BIOT
net/publication/23796818
CITATIONS READS
95 11,442
1 author:
Ninfa M. Rosas-García
Instituto Politécnico Nacional
80 PUBLICATIONS 545 CITATIONS
SEE PROFILE
All content following this page was uploaded by Ninfa M. Rosas-García on 28 May 2014.
Received: October 29, 2008; Accepted: November 26, 2008; Revised: November 28, 2008
Abstract: Since its discovery as a microbial insecticide, Bacillus thuringiensis has been widely used to control insect
pests important in agriculture, forestry, and medicine. The wide variety of formulations based on spore-crystal complexes
intended for ingestion by target insects, are the result of many years of research. The development of a great variety of
matrices for support of the spore-crystal complex enables many improvements, such as an increase in toxic activity,
higher palatability to insects, or longer shelf lives. These matrices use many chemical, vegetable or animal compounds to
foster contact between crystals and insect midguts, without harming humans or the environment.
Biotechnology companies are tasked with the production of these kinds of bioinsecticides. These companies must not only
provide formulations tailored to specific crops and the insect pests, but they must also search for and produce
bioinsecticides based on new strains of high potency, whether wild or genetically improved. It is expected that new
products will appear on the market soon, providing an increased activity spectrum and applicability to many other pest-
impacted crops. These products may help develop a more organic agriculture. This review article discusses recent patents
related to bioinsecticides.
Keywords: Bioinsecticides, formulations, insect pests, biological control, encapsulation, polymers, matrices, insecticidal
preparations, delta-endotoxin, cry genes, insecticidal crystal, toxic activity, lepidopterans, coleopterans, dipterans.
all insects and fungi have a chitin layer covering their required. The bioinsecticide must exhibit stability in storage,
bodies, which is susceptible to degradation by these requiring improvement of its biological and physical
enzymes. The combination of these proteins could enhance properties. The use of additives is required in order to reduce
the potential of this bacterium in biological control evaporation and avoid formulation loss, and to provide a
programs. Another novel B. thuringiensis strain produced by more extended coverage on and high adherence to foliage,
mutagenesis and selection showed enhanced activity against improved dispersion, and a long residual effect. A great
certain plant pathogenic fungi. Such fungi include: Botrytis variety of ingredients have been employed to prepare
cinerea; Alternaria solani; and Aspergillus, etc. Additionally formulations, including liquid or solid carriers, surfactants,
the strain retains the insecticidal activity normally associated coadjuvants, fluidity agents, adherents, dispersants,
with the wild-type strain. The strain designated AU634 stabilizers, moisturizers, attractants, and protective agents
protects plants against damage by the lesser cornstalk borer among others [54]. An interesting and recent example of
and other lepidopteran pests that are ususally susceptible to these kind of inert ingredients is the superabsorbent starch
Cry1Ab and Cry1Ac toxins [50]. graft copolymer, which combined with a B. thuringiensis
strain among many other pesticides constitutes a novel
Cockroaches, belonging to Order Orthoptera, are
formulation that could be applied in an agricultural
common house pests, and they cause serious problems in
environment [55].
hospitals, food industry and agriculture. These pests are
important because their body surface is a vector for several The biological activity of one particular bioinsecticide
microorganisms, many of which are potentially dangerous to was enhanced when the antibiotic zwittermycin was added.
human beings. In many cases, cockroach infestations can This combination was also successful in pest control [56].
elicit allergic reactions in humans. An alternative for their Other compounds with such a synergism have also been
control involves the use of activated toxins of B. used, in amounts effective for enhancing the pesticidal
thuringiensis var. israelensis. In particular, the strain B.t. activity of a B. thuringiensis-based biopesticide. This can
PS123D1 is effective for cockroach control, and a truncated help reduce the amount of B. thuringiensis needed for a
form of a toxin obtained from PS123D1, having particular commercially effective bioinsecticide [57]. Hobbs [58]
activity to cockroaches, is also indicated for use in patented a pesticidal composition comprising a B.
controlling the pest. [51]. thuringiensis biopesticide present at ineffective levels, and a
surfactant present at effective levels in order to control pests
Mite pests are susceptible to the action of B.
thuringiensis. Isolates designated B.t. PS50C, B.t. PS86A1, or to reduce the amount of the B. thuringiensis normally
needed for commercially effective use.
B.t. PS69D1, B.t. PS72L1, B.t. PS75J1, B.t. PS83E5, B.t.
PS45B1, B.t. PS24J, B.t. PS94R3, B.t. PS17, B.t. PS62B1 Bacillus thuringiensis-based products are classified
and B.t. PS74G1 or their mutants were found to be according to their formulation. All products containing a
particularly active against the two-spotted spider mite, blend of spores and crystals from a native strain are
Tetranychus urticae. Furthermore, genes encoding novel classified as first-generation products. These products
delta-endotoxins can be cloned from these isolates and constitute the majority of commercial products. The second-
transferred to other host microbes or plants. Expression of generation products are based on spores and crystals from a
the delta-endotoxins in microbe hosts has resulted in the B. thuringiensis strain bearing artificially introduced genes
control of mite pests, whereas transformed plants become coding for delta-endotoxins from several strains, in order to
resistant to these pests [52]. increase the activity spectrum against other insect pests.
Formulations containing dead recombinant Pseudomonas
BACILLUS THURINGIENSIS-BASED FORMU- fluorescens cells transformed with genes coding for delta-
LATIONS
endotoxins are classified as third-generation products [3].
Bacillus thuringiensis-based biopesticide production An insecticide can be introduced into the market in
depends on high quality, and high-efficiency formulation different forms, depending on the insect to be controlled, the
processes. Formulations must be safe and effective products, kind of crop, and the application method (Table 1). In addi-
must be easy to use, and should have a long shelf life. The tion, the form of any formulation for release or dispensing
active ingredient in commercial formulations is the spore- into the environment is an important consideration. It
crystal complex, which is more effective to use and cheaper depends on the pest to be controlled and the plant to which it
to obtain than the crystals alone, which are frequently used will be applied.
in experimental tests. The spore-crystal complex must be
carried by suitable excipients that can function to protect the An interesting example comes from laboratory research
spore-crystal complex or to increase palatability to insects. to control mosquito larvae [59]. The procedure was patented
In this sense, many studies reveal the inclusion of some in 1999, and four years later, this invention, containing B.
kinds of components, related to enhance toxicity, or to thuringiensis subsp. israelesis suspended in ice granules,
enhance the attraction of insects. A good example is a was applied to control Aedes vexans larvae. The ice granules
formulation developed for killing fire ants that included a containing the toxic agent were prepared in a special ice
purified and activated Cry toxin from a novel strain of B. machine and applied on the water surface where they melted
thuringiensis, along with an attractant consisting of a and released the toxic crystals [60]. This clean technology
biodegradable, environmentally sound glycoprotein [53]. resulted in a very economic and convenient means for the
control of an important disease vector. For other kinds of
Many biodegradable compounds can be considered for dipterans, a solution proposed by Gomes Sanchez et al. [61]
use as inert carriers, depending on the type of formulation
32 Recent Patents on Biotechnology 2009, Vol. 3, No. 1 Ninfa M. Rosas-García
Table 1. Types of Bacillus thuringiensis Formulations and as fluidity and dispersion play an important role. To this end,
Their Applications for Insect Pest Control a patent was granted to Suenaga et al. [62] for improving
dispersibility, suspensibility and hydration tendency in an
Formulation Application agrochemical preparation that included a product derived
from B. thuringiensis var. aizawai (K strain), an inorganic
Emulsions Agriculture and forestry salt (ammonium sulfate) and/or a saccharide (refined sugar),
a surfactant (sodium lignosulfonate), and a binder (silica,
Encapsulations Agriculture and forestry talc, or kaolin).
Wettable powders Gardens and agriculture Today, a great variety of B. thuringiensis-based
Granules Agriculture and forestry bioinsecticides is commercially available for the control of a
wide variety of agriculture and forestry pests, including
Powders Forestry disease vectors [54] Table 2. Many formulations already
exist in the market; however, many patents relate to the use
Briquettes Aquatic systems
of different components that can further improve their
insecticidal activity. In many cases, these products provide
was a bioinsecticide formulation dispensed as a dry powder interesting advantages over previously developed insec-
or tablet. Formulations contained B. thuringiensis var. ticides [63-65]. Fig. (3) shows the abundance of intellectual
israelensis and chemical dryers, dispersing agents, binding property developed in B. thuringiensis around the world
agents and moisturizing agents, protectors against sunlight; during the last 22 years.
and optionally, diluents, lubricant and neutralizing agents.
The bioinsecticide obtained was considered to be an GENES, NUCLEOTIDES SEQUENCES, TOXINS, AND
ecologically safe product. OTHERS
As mentioned above, physical properties must always be The majority of the patents in B. thuringiensis relate to
considered when appropriate formulations are being the discovery of novel genes associated with toxicity, or to
developed. For successful field applications, properties such the characterization of nucleotide sequences that could be
AFA Environment Inc. Agribac B. thuringiensis v. kurstaki More than 30 insect species
Valent Biosciences Corp. XenTari B. thuringiensis v. kurstaki Particularly effective against Spodoptera ssp.
and Plutella xilostella
Valent Biosciences Corp. VectoBac B. thuringiensis v. israelensis Mosquito and fly larvae
Valent Biosciences Corp. Teknar B. thuringiensis v. israelensis Mosquito and black fly larvae
Valent Biosciences Corp. GnatrolDG B. thuringiensis v. israelensis Larval stage of Sciarid mushroom flies
Valent Biosciences Corp.* Thuricide B. thuringiensis v. kurstaki Lepidopterans and certain leaf-eating worms
*Valent BioSciences has also acquired exclusive marketing rights to Thuricide biological insecticide. Thuricide is a registered trademark of Certis, USA.
B. thuringiensis Based-Biopesticides Recent Patents on Biotechnology 2009, Vol. 3, No. 1 33
Fig. (3). Number of patents granted and applications related to B. thuringiensis inventions in the last 22 years. Data were obtained from the
World Intellectual Property Organization, the United States Patent and Trademark Office, the European Patent Office and the Japan Patent
Office. Inventions related to B. thuringiensis transgenic plants are not included in this graphic.
used as probes and primers for identification of genes species [84], are some of the patents that relate to the
encoding toxins, and of the toxins themselves. Many patents discovery of novel genes with insecticidal activity. In
disclose new families of toxins. For example a recent patent addition, compositions, methods, and other procedures are
revealed a novel insecticidal crystal protein gene cry7Bal requisite for the study of these bacteria. Any novel
from B. thuringiensis subsp. huazhongensis YBT-978, which component can be intellectually protected, as demonstrated
encodes a novel crystal protein with toxic activity against by the following patents: Carozzi et al. [85] patented
lepidopteran insects [66]. Bermudez et al. [67] patented compositions and methods for conferring pesticidal activity
insecticidal polypeptides related to Cry2 proteins, including to bacteria, plants, plant cells, tissues and seeds, as well as a
the nucleic acids which encode them, and the methods for coding sequence for a delta-endotoxin to be used in DNA
using them to enhance resistance of plants to insect feeding. constructs or expression cassettes for transformation and
Other nucleic acids, variants and fragments obtained from B. expression in plants and bacteria, and delta-endotoxin-
thuringiensis strains, encoding polypeptides with toxic associated polypeptides. Adams et al. [86] patented another
activity against insect pests including coleopterans, have method for producing an integrant(s) of B. thuringiensis that
been patented [68]. Novel isolates, insecticidal toxins, genes, produces a larger quantity of a crystal delta-endotoxin with
nucleotide probes and primers for the identification of genes greater pesticidal activity as compared to the crystal delta-
provided entirely new families of toxins [69-74]. The endotoxin produced by the corresponding parental strain.
isolation and characterization of nucleotide sequences The crystal delta-endotoxin produced by the integrant B.
encoding novel insecticidal proteins includes new DNA thuringiensis will have an activity directed towards the same
sequences encoding proteins designated as Cry9Fa, Cry1Jd, pest(s) as its parent B. thuringiensis crystal delta-endotoxin.
and Cry1Bf, useful to protect plants from insect damage The invention further relates to such integrants, compositions
[75], recombinant DNA sequences encoding pesticidal comprising such integrants, as well as methods for
proteins designated as ISLP proteins, and toxic fragments controlling pests using these compositions. Another similar
[76]. Carozzi et al. [77] and Abad et al. [78, 79] have patent by Adams et al. [87] discloses an integrant of B.
described representative patents in which the insecticidal thuringiensis that produces a larger quantity of a crystal
activity has been directed toward different insect pests, delta-endotoxin with greater pesticidal activity and optio-
particularly to protect plants from pest damage [80, 81]. nally a larger crystal size as a result of gene amplification or
hyperexpression, as compared to the corresponding parental
Novel insecticidal compounds derived from B.
strain. The integrant strain will have an activity directed
thuringiensis strains and new proteins designated Cry2Ae,
towards the same pest as the corresponding parental strain
Cry2Af, and Cry2Ag [82], lepidopteran toxic proteins
delta-endotoxin.
designated as CryET4 and CryET5 from strain EG5847 [83],
delta-endotoxins polypeptides designed CryET10 active CHIMERIC CRYSTAL PROTEINS
against lepidopteran and coleopteran pests as well as
methods for controlling an insect population, such as the In recent years, hybrid delta-endotoxins have arisen as
Western corn rootworm and Colorado potato beetle, and for proteins with potential for enhanced toxic activity or
conferring to a plant population resistance to the target insect improved properties. Recent advances in molecular
methodologies have allowed gene fusions and chimeric
34 Recent Patents on Biotechnology 2009, Vol. 3, No. 1 Ninfa M. Rosas-García
protein construction. This construction can include alteration hybrid toxin fragment comprises at its C-terminus domain III
of amino acid sequences, fusion of portions of two or more a first Cry protein, and at its N-terminus, a second Cry
proteins together into a single recombinant protein, or protein [95].
alteration of the genetic sequences encoding for proteins
An isolated B. thuringiensis Cry8Bb1 toxin polypeptide
with commercial application. Although this is not an easy with at least one engineered proteolytic protection site is not
process for Cry proteins, due to their complex nature, a
sensitive to a plant protease and protects the toxin
careful selection of target regions in the protein will allow
polypeptide from proteolytic inactivation in a plant. The
the production of engineered toxins with a high insecticidal
proteolytic protection site comprises the amino acid
activity. A number of advances have been made to improve
sequence NGSRNGSR and replaces a proteolytic site that
the desirable properties of bioinsecticides.
comprises the amino acid sequence FRRGFRRGH. This
In the continuous struggle against lepidopteran pests, the invention is used for controlling agriculturally significant
synergistic combination of a CryIF chimeric and CryIA(c) pests, such as the Western corn rootworm, Diabrotica
chimeric B. thuringiensis delta-endotoxin exhibited excellent virgifera virgifera; the Northern corn rootworm, D. longi-
toxic activity [88]. cornis barberi; the Southern corn rootworm, D. unde-
cimpunctata howardi; wireworms of the genera Melanotus,
A wider spectrum of toxicity is shown by mutant toxins,
which possess toxicity against a variety of insect genera, and Aeolus; the boll weevil Anthonomus grandis; the
Colorado potato beetle Leptinotarsa decemlineata; and the
particularly mosquitoes from the genera Culex, Aedes, and
alfalfa weevil Hypera nigrirostris [96].
Anopheles. The toxin Cry4Ba was modified by substitution
of the amino acid aspartic acid at position 454 with proline, CURRENT & FUTURE DEVELOPMENTS
glycine, alanine, threonine or serine; and by insertion of two
additional amino acids immediately after position 454, There is a great amount of scientific research on the
wherein the additional amino acids are chosen from the bacterium B. thuringiensis, involving aspects ranging from
group consisting of: glycine, alanine, valine, leucine, its molecular biology to its activity in a bioinsecticide.
isoleucine, methionine, proline, threonine, and serine. The Although B. thuringiensis has been studied for more than a
modified Cry4Ba protein exhibits enhanced toxicity to century, it is amazing to know that scientists always find
Culex, as compared to Cry4Ba protein. Cry19Aa has something new in it. The fascinating arrangement of its
undergone modifications or at one or more positions within genetic content, along with the high diversity of toxins
the amino acid sequence [89]. After studying the chimeric derived from it, makes this bacterium a unique organism.
gene segments and the methods for making synthetically New activities for it are discovered daily, and as a result,
modified chimerical crystal proteins, some chimeric crystal more pests can be controlled with environmentally clean
proteins provide a new tool to control insects, particularly technologies. The toxic activity of B. thuringiensis is highly
coleopteran, dipteran, and lepidopteran pests [90]. Other specific and it is practically harmless to human, vertebrates,
novel synthetically modified chimeric crystal proteins having beneficial insects and other organisms.
improved insecticidal activity and a broader insect host range The development of formulations with biodegradable
against coleopteran, dipteran and lepidopteran insects, as ingredients is a favored approach for the reduction of chemi-
well as the nucleic acid segments encoding these novel cal insecticide use, which can threaten the environment.
peptides, were disclosed [91].
Although there is an enormous possibility to control
Modified Cry35 proteins whose segments, domains, and many pests, mainly in agriculture and forestry, and to obtain
motifs were exchanged with other proteins showed enhanced more organic pest-control products, the ignorance about
insecticidal properties relative to the wild type Cry 35 advantages of use of B. thuringiensis products limits its
protein, and this invention provided good control against application; therefore, it is necessary to establish measures
plant pests including rootworms [92]. Another chimeric aimed at promoting the knowledge of biological control
protein, formed from delta-endotoxins Cry1Ea and Cty1Ca, programs. Intellectual property is the only tool that one can
resulted in an extraordinarily high insecticidal activity in possesses for the protection of his or her inventions, and said
recombinant plants [93]. inventions, as in the B. thuringiensis case, must be exploited
An interesting patent discloses new chimeric genes for their benefits to human health and environmental
encoding a Cry1C, Cry1B or Cry1D protein that are useful in friendliness.
the protection of plants from insect damage [94]. ACKNOWLEDGEMENTS
One particular hybrid crystal protein is composed of This work received financial support by the Secretaría de
proteins CryIC together with CryIE, CryIA, or CryIG. The Investigación y Posgrado del Instituto Politécnico Nacional,
nucleotide sequence of the CryIC gene is obtained from B. project No. 20080218.
thuringiensis subsp. entomocidus 60.5. The nucleotide
sequence of the CryIE gene derived from B. thuringiensis CONFLICT OF INTEREST
subsp kenyae 4FI. The nucleotide sequence of the CryIG The author has no conflict of interest to declare.
gene derived from another B. thuringiensis strain. These
proteins are toxic to lepidopterans, but within this order of REFERENCES
insects, each protein has different specificity. CryIC, for [1] Aizawa K. Shigetane Ishiwata: His discovery of sottokin (Bacillus
example, is particularly active against Spodoptera exigua thuringiensis) in 1901 and subsequent investigations in Japan.
and Mamestra brassicae. The isolated B. thuringiensis Proceedings of a Centennial Symposium Commemorating
Ishiwata’s Discovery of Bacillus thuringiensis. Japan 2001.
B. thuringiensis Based-Biopesticides Recent Patents on Biotechnology 2009, Vol. 3, No. 1 35
[2] Lord JC. From Metchnikoff to Monsanto and beyond: The path of [24] Mathavan S, Sudha PM, Pechimithu SM. Effect on Bacillus
microbial control. J Invertebr Pathol 2005; 89 (1): 19-29. thuringiensis on the midgut cells of Bombix mori larvae: A
[3] Cerón JA. Productos comerciales nativos y recombinantes a base histopahological and histochemical study. J Invertebr Pathol 1989;
de Bacillus thuringiensis. Bioinsecticidas: Fundamentos y 53: 217-227.
aplicaciones de Bacillus thuringiensis en el control integrado de [25] Crickmore N, Zeigler DR, Feitelson J, et al. Revision of the
plagas. In: Caballero P, Ferré J. Eds, Phytoma-España 2001; 153- nomenclature of the Bacillus thuringiensis pesticidal crystal
168. proteins. Microbiol Mol Biol Rev 1998; 62: 807-813.
[4] Aronson A, Beckman W, Dunn P. Bacillus thuringiensis and [26] Galán-Wong LJ, Pereyra-Alférez B, Luna-Olvera HA. Bacterias
related insect pathogens. Microbiol Rev 1986; 50 (1): 1-24. entomopatógenas. Biotecnología financiera aplicada a biopla-
[5] Nester EW, Thomashow LS, Metz M, Gordon M. 100 years of guicidas. In: García-Gutiérrez C, Medrano-Roldán H, Eds. México
Bacillus thuringiensis: A critical scientific assessment. American 2006; pp. 43-63.
Academy of Microbiology. Washington DC 2002. [27] Jarret P, Stephenson M. Plasmid transfer between strains of
[6] King E. Control biológico de insectos y ácaros plaga. Avances Bacillus thuringiensis infecting Galleria mellonella and Spodop-
recientes en la biotecnología en Bacillus thuringiensis. In: Galán- tera littoralis. Appl Environ Microbiol 1990; 56(6): 1608-1614.
Wong LJ, Rodríguez-Padilla C, Luna-Olvera HA, Eds. Universidad [28] Van Frankenhuyzen K, Gringorten JL, Gauthier D, Milne RE,
Autónoma de Nuevo León 1996; 13-19. Mason L, Peferoen M. Toxicity of activated CryI proteins from
[7] Margalith Y, Ben-Dov E. Biological control by Bacillus Bacillus thuringiensis to six forest lepidoptera and Bombyx mori. J
thuringiensis subp. israelensis. Insect pest management, techniques Invertebr Pathol 1993; 62: 295-301.
for environmental protection. In: Rechcigl JE, Rechcigl NA, Eds. [29] Bohorova N, Cabrera M, Abarca C, et al. Susceptibility of four
Lewis Publishers 2000; 243-301. tropical lepidoperan maize pests to Bacillus thuringiensis CryI-type
[8] Aizawa K. Selection and utilization of Bacillus thuringiensis insecticidal toxins. J Econ Entomol 1997; 90(2): 412-415.
strains for microbial control. 1st. Intersectional Congress of the [30] Reed JP, Halliday WR. Establishment of Cry9C susceptibility
International Association of Microbiological Societies. Tokyo baselines for European corn borer and southwestern corn borer
(1974). (Lepidoptera: Crambidae). J Econ Entomol 2001; 94: 397-402.
[9] Schnepf EN, Crickmore J, Van Rie D, et al. Bacillus thuringiensis [31] Gomes Monera, R, Cardoso Batista A, Telles de Medeiros P, et al.
and its pesticidal crystal proteins. Microbiol Mol Biol Rev 1998; 62 Screening of Brazilian Bacillus thuringiensis isolates active against
(3): 775-806. Spodoptera frugiperda, Plutella xylostella and Anticarsia
[10] Joung KJ, Côté JC. A review of the enviromental impacts of the gemmatalis. Biological Control 2007; 41(3): 291-295.
microbial insecticida Bacillus thuringiensis. Technicall Bulletin [32] Ibargutxi MA, Muñoz D, Ruiz de Escudero I, Caballero P.
No. 29 Horticultural Research and Development Centre. Canada Interactions between Cry1Ac, Cry2Ab, and Cry1Fa Bacillus
2002. thuringiensis toxins in the cotton pest Helicoverpa armígera
[11] Iriarte J, Caballero P. Biología y ecología de Bacillus thuringiensis. (Hübner) and Earias insulana (Boisduval). Biological Control
Bioinsecticidas: Fundamentos y Aplicaciones de Bacillus 2008; 47 (1): 89-96.
thuringiensis en el Control Integrado de Plagas. Caballero P, Ferré [33] Seifinejad A, Salehi Jouzani GR, Hosseinzadeh A, Abdimishani C.
J, Eds. Phytoma-España 2001; pp. 15-44. Characterization of Lepidoptera-active cry and vip genes in Iranian
[12] Bravo A, Gill SS, Soberón M. Mode of action of Bacillus Bacillus thuringiensis strain collection. Biological Control 2008; 44
thuringiensis Cry and Cyt toxins and their potential for insect (2): 216-226.
control. Toxicon 2007; 49: 423-435. [34] Lambert, B., Jansens, S., Van Audenhove, K., Peferoen, M.:
[13] de Maagd RA, Bravo A, Crickmore N. How Bacillus thuringiensis US20087361751 (2008).
has evolved specific toxins to colonize the insect world. Trends [35] Abad, A., Dong, H., Lo, S., Shi, X., WO2008011584 (2008).
Genet 2001; 17: 193-199. [36] Baum, J.A., Chu, C.-R., Donovan, W.P., Gilmer, A.J., Rupar, M.J.:
[14] Höfte H, Whiteley HR. Insecticidal crystal proteins of Bacillus US20067332594 (2006).
thuringiensis. Microbiol Rev 1989; 53: 242-255. [37] Lysyk, T.J., Selinger, L.B., Kalischuk-Tymensen, L.D., Lancaster,
[15] Agrawal N, Malhotra P, Bhatnagar RK. Interation of gene-cloned R.C., Baines, D.D.S.: WO2006042404 (2006).
and insect cell-expressed aminopeptidase N of Spodoptera litura [38] Abad, A.R., Duck, N.B., Feng, X., Flannagan, R.D., Khan, T.W.,
with insecticidal crystal protein Cry1C. Appl Environ Microbiol Sims. L.E.: EP1356054 (2003).
2002; 68(9): 4583-4592. [39] Narva, K.E., Schnepf, H.E., Knuth, M., Pollard, M.R., Cardineau,
[16] Lee MK, You TH, Young BA, Cotrill JA, Valaitis AP, Dean DH. G.A., Schwab, G.E., Michaels, T.E.: US20087355003 (2008).
Aminopeptidase N purified from gypsy moth brush border [40] Abad, A.R., Flannagan, R.D., McCutchen, B.F., Yu, C.G.:
membrane vesicles is a specific receptor for Bacillus thuringiensis US20087329736 (2008).
Cry1Ac toxin. Appl Environ Microbiol 1996; 62(8): 2845-2849. [41] Payne, J.M., Kennedy, M.K., Randall, J.B., Meier, H., Uick H.:
[17] Vadlamudi RK, Weber E, Ji I, Ji TH, Bulla Jr LA. Cloning and EP1065275 (2001).
expression of a receptor for an insecticidal toxin of Bacillus [42] Riazuddin, S.: EP0983362 (2000).
thuringiensis. J Biol Chem 1995; 270 (10): 5490-5494. [43] Narva, K.E., Payne, J.M., Schwab, G.E., Hickle, L.A., Galasan,
[18] Jurat-Fuentes JL, Adang MJ. Characterization of a Cry1Acreceptor T.,Sick, A.J.: JP2007006895 (2007).
alkaline phosphatase in susceptible and resistant Heliothis [44] Thompson, M., Knuth, M., Cardineau, G.: US20046831062 (2004).
virescens larvae. Eur J Biochem 2004; 271: 3127-3135. [45] Thompson, M., Gaertner, F.H.: EP0461799 (1991).
19] Valaitis AP, Jenkins JL, Lee MK, Dean DH, Garner KJ. Isolation [46] Koziel, M.G., Desai, N., Deter, R., Tomso, D.J., Hargiss, T., Duck,
and partial characterization of Gypsy moth BTR-270 an anionic N., Carozzi, N., Guo, R.: WO2007147096 (2007).
brush border membrane glycoconjugate that binds Bacillus [47] Mizushiro, H., Akao, T., Yamashita, S., Oba, M., Kondo,
thuringiensis Cry1A toxins with high affinity. Arch Ins Biochem S.,Maeda, M.: JP2002284800 (2002).
Physiol 2001; 46: 186-200. [48] Aroian, R., Li, X.-Q.: WO2007062064 (2007).
[20] Lorence A, Darszon A, Díaz C, Liévano A, Quintero R, Bravo A. [49] Maeda, M., Oba M., Mizushiro, H., Itami, T., Inuzuka, H.:
Endotoxins induce cation channels in Spodoptera frugiperda brush JP2005154405 (2005).
border membranes in suspension and in planar lipid bilayers. FEBS [50] Moar, W.: US20016280722 (2001).
Lett 1995; 360 (3): 217-222. [51] Schnepf, H.E., Randall, J.B., Payne, J.M.: WO9600502 (1997).
[21] Aronson AI, Geng C, Wu L. Aggregation of Bacillus thuringiensis [52] Payne, J.M., Cannon, R.J.C., Bagley, A.L.: WO9219106 (1992).
Cry1A toxins upon binding to target insect larval midgut vesicles. [53] Bulla, L.A.Jr., Candas, M.: WO0140476 (2002).
Appl Environ Microbiol 1999; 65: 2503-2507. [54] Morales-Ramos L.H. Formulación de Bioinsecticidas. Avances
[22] Lacey LA, Federici BA. Pathogenesis and midgut histopathology recientes en la Biotecnlogía en Bacillus thuringiensis. In: Galán-
of Bacillus thuringiensis in Simulium vittatum (Dipetra: Simulidae). Wong LJ, Rodríguez-Padilla C, Luna-Olvera HA, Eds. Universidad
J Invertebr Pathol 1979; 33: 171-182. Autónoma de Nuevo León 1996; pp. 157-177.
[23] Endo Y, Nishiitsutsuji-Uwo J. Mode of action of Bacillus [55] Savich, M.H., Olson, G.S., Clark, E.W., Doane, W.M., Doane,
thuringiensis delta endotoxin: Histopathological changes in the S.W.: US20087425595 (2008).
silkworm midgut. J Invertebr Pathol 1980; 36: 90-103. [56] Schnepf, H.E., Stockhoff, B., Knuth, M.: US5702703 (1994).
[57] Kahn, R., Orgambide, G.: WO9628023 (1996).
36 Recent Patents on Biotechnology 2009, Vol. 3, No. 1 Ninfa M. Rosas-García
[58] Hobbs, D.G.: WO9618302 (1996). 76] Baum, J., Donovan, J., Donovan, W., Engleman, J.T., Krasomil-
[59] Becker N. Ice granules containing endotoxins of microbial agents Osterfeld, K., Pitkin, J.W., Roberts, J.K.: WO2005019414 (2006).
for the control of mosquito larvae- a new application technique. J [77] Carozzi, N., Hargiss, T., Koziel, M., Duck, N., Carr, B.:EP1947184
Am Mosq Control Assoc 2003; 19(1): 63-66. (2008).
[60] Becker, N., Mercatoris, P.: EP0948259 (1999). [78] Abad, A., Dong, H., Lo, S.B., McCutchen, B.F., Shi, X.:
[61] Gomes Sanchez, E., Batista Da Silva, A.C., Abreu Campos, F.M., WO2008011565 (2008).
Pinheiro, R.A., De Assuncao, F.J.: WO0189297 (2001). [79] Abad, A.R., Flannagan, R.D., McCutchen, B.F., Yu, C.G.:
[62] Suenaga, S., Miyazaki, H., Inada, M.: JP2001010915 (2001). US20087329736 (2008).
[63] http://www.certisusa.com/products/turex-agree-wpbioinsecticide. [80] Abad, A., Flannagan, R.D., Herrman, R., Kahn, T.W., Lu,
htm. Date of access 10th/Sep/08 A.L.,McCutchen, B.F., Presnail, J.K., Wong, J.F.H., Yu, C.G.:
[64] http://danesh.ca/afa/afaenvironment.com/engl/index.html. Date of US20067105332 (2006).
access 10th/Sep/08 [81] Soberon-Chavez, M., Bravo de la Parra, A.: WO2007007147
[65] http://www.valentbiosciences.com/agricultural_products/ (2007).
agricultural_products _5.asp. Date of access10th/Sep/08 [82] Arnaut, G., Boets, A., Vanneste, S., Van Rie, J., Van Houdt, S.:
[66] Sun, M., Yu, Z., Chen, S., Zhang, Z., Ruan, L., Guo, S., Dai, J., Li, US20077265269 (2007).
L., Liu, Z.: EP1937818 (2008). [83] Donovan, W.P., Gonzalez, Jr.J.M.: US5854053 (1998).
[67] Bermudez, E., Emig, R., McBride, K., Yamamoto, T.: [84] Mettus, A.-M., Baum, J.: EP1129198 (2001).
WO2005082077 (2006). [85] Carozzi, N., Hargiss, T., Koziel, M., Duck, N., Carr, B.:
[68] Abad, A.R., Dong, H., Lo, S., Shi, X.: WO2008011586 (2008). EP1947184 (2008).
[69] Feitelson, J.S., Schnepf, H.E., Narva, K.E., Stockhoff, B.A., [86] Adams, L.F., Thomas, M.D., Sloma, A.P., Widner, W.R.:
Schmeits, J., Loewer, D., Dullum, C.J., Muller.Cohn, J., Stamp, L., WO9502695 (1995).
Morril, G., Finstad-Lee, S.: EP1944372 (2008). [87] Adams, L.F., Thomas, M.D., Sloma, A.P., Widner, W.R.:
[70] Carozzi, N., Duck, N., Kahn, T., Desai, N., Jain, S., Tomso, D.J., US20016280720 (2001).
Guo, R., Thissen, J.: WO2007147029 (2007). [88] Bradfisch, G., Thompson, M., Schwab, G.: US5128130 (1998).
[71] Carozzi, N., Koxiel, M., Hargiss, T., Duck, N., Kahn, T.: [89] Dean, D.H., Abdullah, M.A.: US20087393922 (2008).
WO2006119457 (2006). [90] Malvar, T., Gilmer, A.J.: US20036521442 (2003).
[72] Carozzi, N., Hargiss, T., Koziel, M., Duck, N., Kahn, T.: [91] Malvar, T., Mohan, S., Sivasupramaniam, S.: WO0214517 (2002).
WO2006107761 (2006). [92] Schnepf, H.E., Narva, K.E., Evans, S.L.: US20077309785 (2007).
[73] Carozzi, N., Hargiss, T., Koziel, M.G., Duck, N., Carr, B.: [93] Tuli, R.: WO03082910 (2003).
WO2004074462 (2004). [94] Van Rie, J., Meulewaeter, F., Van, E.G.: WO2007107302 (2007).
[74] Koziel, M., Desai, N., Deter, R., Tomso, D.J., Hargiss, T., Duck, [95] Bosch, H.J., Stiekema, W.J.: US20046780408 (2004).
N.B., Carozzi, N., Guo, R.: WO2007147096 (2007). [96] Abad, A., Dong, H., Herrmann, R., Lu, A., McCutchen, B.F., Rice,
[75] Boets, A., Damme, N., Mathieu, E., Vanneste, S., Van Rie, J.: J., Schepers, E., Wong, J.: US20087378499 (2008).
US20087361808 (2008).